FERTILITY-SPARING TREATMENT OF STAGE 1 ENDOMETRIAL CANCER AND COMPLEX ATYPICAL HYPERPLASIA: PREDICTIVE FACTORS FOR REGRESSION AND REPRODUCTIVE OUTCOMES.

被引：0
|
作者：
Chuong, F. S. [1 ]
Yates, M. M. [2 ]
Wu, J. [1 ]
Garcia, J. [1 ]
Kolp, L. [1 ]
Christianson, M. S. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Dept Gynecol & Obstet, Lutherville Timonium, MD USA
[2] Adv Reprod Specialists Orlando, Winter Pk, FL USA
来源：
FERTILITY AND STERILITY | 2014年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2014.07.552
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-67
引用
收藏
页码：E161 / E161
页数：1
相关论文
共 50 条
  • [41] Fertility-sparing treatment in women with endometrial cancer
    Won, Seyeon
    Kim, Mi Kyoung
    Seong, Seok Ju
    [J]. CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2020, 47 (04): : 237 - 244
  • [42] Fertility-Sparing Treatment and Assisted Reproductive Technology in Patients with Endometrial Carcinoma and Endometrial Hyperplasia: Pregnancy Outcomes after Embryo Transfer
    Friedlander, Hilary
    Blakemore, Jennifer K.
    McCulloh, David H.
    Fino, M. Elizabeth
    [J]. CANCERS, 2023, 15 (07)
  • [43] Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
    Yiqin Wang
    Rong Zhou
    Xiaobo Zhang
    Huixin Liu
    Danhua Shen
    Jianliu Wang
    [J]. BMC Women's Health, 21
  • [44] Outcomes of fertility-sparing treatment with progestin in patients with early-stage endometrial cancer or severe atypical hyperplasia: Preliminary results of a phase II study in China
    Shen, K.
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 : 91 - 91
  • [45] Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
    Yang, Bingyi
    Xie, Liying
    Zhang, Hongwei
    Zhu, Qin
    Du, Yan
    Luo, Xuezhen
    Chen, Xiaojun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
  • [46] Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
    Wang, Yiqin
    Zhou, Rong
    Zhang, Xiaobo
    Liu, Huixin
    Shen, Danhua
    Wang, Jianliu
    [J]. BMC WOMENS HEALTH, 2021, 21 (01)
  • [47] Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
    Ronsini, Carlo
    Mosca, Lavinia
    Iavarone, Irene
    Nicoletti, Roberta
    Vinci, Davide
    Carotenuto, Raffaela Maria
    Pasanisi, Francesca
    Solazzo, Maria Cristina
    De Franciscis, Pasquale
    Torella, Marco
    La Verde, Marco
    Colacurci, Nicola
    Cobellis, Luigi
    Vizzielli, Giuseppe
    Restaino, Stefano
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer
    Myung Joo Kim
    Seung-Ah Choe
    Mi Kyoung Kim
    Bo Seong Yun
    Seok Ju Seong
    You Shin Kim
    [J]. Archives of Gynecology and Obstetrics, 2019, 300 : 975 - 980
  • [49] Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer
    Kim, Myung Joo
    Choe, Seung-Ah
    Kim, Mi Kyoung
    Yun, Bo Seong
    Seong, Seok Ju
    Kim, You Shin
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (04) : 975 - 980
  • [50] Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience
    Shikeli, Sumaya
    Gowri, Vaidyanathan
    Al Rawahi, Thuria
    [J]. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2020, 24 (04): : 466 - 469
12345